Merck succeeds before Brazilian courts on compelling the Brazilian Patent Office (BRPTO) to expedite examination of patent applications pending for over 12 years.MERCK & CO, INC, one of the larges users of the Brazilian patent system obtained a favorable judgement from Brazilian Federal Courts granting expedited examination of a patent application covering Temodal IV filed […]
For the third time in less than 6 months, the Ministry of Health (MoH) changes the market share of PDPs involving monoclonal antibodies and etanercept.On July 14, 2017, the MoH republished Ordinance #542 of 2017 (Ordinance #542), allocating for the third time the market shares of the PDPs involving monoclonal antibodies (adalimumab, bevacizumab, infliximab, rituximab […]
Brazilian PTO (BRPTO)’s Normative Instruction #01/2017 on procedures for pharmaceutical patent applications under art. 229-C of the Patent Statute issued. New instruction implements Interagency Ordinance #1 of 2017.(BRPTO’s IP gazette #2425 of June 27th, 2017)The BRPTO published on June 27, 2017, Normative Instruction #01/2017, [NI #01/2017] which establishes the procedures to be followed by the […]
(BRPTO’s website communication of June 22nd, 2017)The BRPTO published today, June 22nd, 2017, a communication on its official website (www.inpi.gov.br) informing the decision to revoke Rule #193/2017, issued on June 13th, 2017. This Rule established the incorporation of prior art search reports issued by International Searching Authorities (ISA) and International Preliminary Examining Authorities (IPEA), in […]
(BRPTO’s IP gazette of June 13th, 2017)The BRPTO published today, June 13th, 2017, Rule #193/2017 which establishes the use of priorart search reports issued by International Searching Authorities (ISA) and International Preliminary Examining Authorities (IPEA), hereinafter “reference offices” (Annex I), for patent applications filed under the PCT Agreement.According to Article 3 of Rule #193/2017, prior […]
